Sort   by:  
 Page size 
EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 72 hours. Unpowered exploratory experiment. Sample size: 3x3.
ORGANISM(S): Homo sapiens (Human) 
2022-04-07 | PXD027921 | Pride
PCSK9 knockdown in EndoC-bH1 cells at 72 hours
EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 72 hours. The experiment was powered based PCSK9 knockdown in a pilot experiment. Sample size: 12x12.
ORGANISM(S): Homo sapiens (Human) 
2022-04-07 | PXD027911 | Pride
EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 72 hours. The experiment was powered based PCSK9 knockdown in the pilot experiment [PXDxxx (PE083)]. Sample size: 12x12.
ORGANISM(S): Homo sapiens (Human) 
2022-04-07 | PXD027913 | Pride
EndoC-bH1 cells proteomics was assessed in untreated baseline condition and after treatment with control siRNA at 24, 48 and 72 hours. Unpowered exploratory experiment. Sample size: triplicate per condition.
ORGANISM(S): Homo sapiens (Human) 
2022-04-07 | PXD027898 | Pride
EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 24, 48 and 72 hours. Untreated baseline samples were also included. Unpowered exploratory experiment. Sample size: triplicate per condition.
ORGANISM(S): Homo sapiens (Human) 
2022-04-07 | PXD027920 | Pride
Transcription profiling of KCTD17 knockdown human beta-cell line EndoC-bH1
RNA-Sequencing of EndoC-BH1 cells Overexpressing OAS1, OAS2, or OAS3
Gene expression in EndoC-bH1 human beta-cell line
m6A Regulator ALKBH5 Binbing RNA Identified by eCLIP in Human beta-cell line EndoC-bH1
Sort   by:  
 Page size